Johnson & Johnson COVID-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says

Name: Johnson & Johnson COVID-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says
Uploaded: 2021-01-29T22:24:12+00:00
Duration: P229S
Description: Johnson & Johnson’s one-shot vaccine candidate was found to be 85% effective against the most serious symptoms of COVID-19.

Video Credit: WXYZ Detroit - Duration: 03:49s - Published on January 29, 2021

Johnson & Johnson COVID-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says

Johnson & Johnson’s one-shot vaccine candidate was found to be 85% effective against the most serious symptoms of COVID-19.

0 shares	Share Tweet Save Post Send

Related videos from verified sources

Johnson & Jonson vaccine 66% effective [Video]

Johnson & Jonson vaccine 66% effective

Johnson & Jonson vaccine 66% effective

Credit: FOX 4 Now Florida Duration: 00:26Published on January 30, 2021

Healthcare workers stranded in snow give out vaccine doses set to expire [Video]

Healthcare workers stranded in snow give out vaccine doses set to expire

A team of healthcare workers in Oregon stuck in a snowstorm carrying doses of the Covid-19 vaccine that were set to expire set up an impromptu clinic knocking on car windows and vaccinating stranded..

Credit: Bleacher Report AOL Duration: 03:23Published on January 30, 2021